By Shirley, MI on 6/12/2026 By P, CA on 8/10/2024 By Shirley, MI on 5/26/2023 By Janice, CA on 6/5/2020
If a drug is found to be defective or unreasonably dangerous, patients may have grounds for a lawsuit
How Does It Compare to Other Options Like Tirzepatide or Semaglutide Alone
The legal and safety landscape for research peptides is increasingly hostile
While the research shows promise, especially for heart failure and after heart attacks, there are concerns about a byproduct called TMAO, which might increase the risk of clogged arteries
The main reason for using NEM, IAA or 2-VP is not the improvement of the LC and MS/MS properties of GSH, but to avoid artificial oxidation of GSH to GSSG, even if, as stated before, they are not equally effective to this purpose